AstraZeneca's Wainua fails key heart disease trial, shares tumble
By Raechel Thankam Job July 9 (Reuters) - AstraZeneca's nerve disease drug Wainua, made in partnership with Ionis, ...
A drug already in human trials could reverse tooth loss by 2030, a condition that affects millions
A Japanese biotech company is testing a drug designed to do what modern dentistry has never managed: regrow real, natural ...
FDA expands use of first sickle cell disease gene therapy for children as young as 2 years
The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ...
BioSpace
Amgen continues to defend Tavneos as global regulatory pressure mounts
Regulators on both sides of the Atlantic are pushing for the withdrawal of the rare disease treatment that accounted for just 1% of Amgen’s 2025 revenue. Nevertheless, Amgen continues to defend the ...
BioSpace
Amgen recalls almost 1 million bottles of heart failure drug over quality issue
Amgen has recalled almost 1 million bottles of its chronic heart failure drug Corlanor in response to a contamination concern. The FDA attributed Amgen’s action to the presence of a foreign substance.
Science Daily
The Ozempic and Wegovy mistake sending thousands to poison control
Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, ...
The Genes That Could Cancel Out a Fatal Diagnosis
Abraham Lincoln, for one, may have had the syndrome—and are at very high risk of a kind of fatal rupture in the heart.